Objective: This study aims to evaluate the impact and potential prognostic roles of the pre- and post-treatment Glasgow prognostic score (GPS) and the change thereof in patients with advanced head and neck cancer unde...Objective: This study aims to evaluate the impact and potential prognostic roles of the pre- and post-treatment Glasgow prognostic score (GPS) and the change thereof in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy (CCRT). Methods: We collected GPS and clinicopathological data of 139 stage III, IVA, and IVB head and neck cancer patients who underwent CCRT between 2008 and 2011. Their GPSs pre- and post-CCRT and the change thereof were analyzed for correlations with recurrence and survival. Results: The GPS changed in 72 (51.8%) patients, with worse scores observed post-CCRT in 65 (90.3%) of the GPS changed patients. Patients in the improved GPS group showed a tendency toward better survival. From the multivariate analysis, the post-CCRT GPS level was an independent prognostic factor in addition to tumor stage. Conclusions: After CCRT, a high GPS was revealed to be an important predictor of survival for advanced head and neck cancer.展开更多
BACKGROUND Some studies investigated the prognostic role of several blood biomarkers,including the neutrophil/lymphocyte ratio(NLR),platelet/lymphocyte ratio(PLR),lymphocyte/monocyte ratio(LMR)and Glasgow prognostic s...BACKGROUND Some studies investigated the prognostic role of several blood biomarkers,including the neutrophil/lymphocyte ratio(NLR),platelet/lymphocyte ratio(PLR),lymphocyte/monocyte ratio(LMR)and Glasgow prognostic score(GPS),in osteosarcoma,but their results were inconsistent with each other.AIM To identify the prognostic value of NLR,PLR,LMR and GPS in osteosarcoma patients through reviewing relevant studies.METHODS The PubMed,EMBASE,Web of Science and CNKI databases were searched up to October 2,2021.The primary and second outcomes were overall survival(OS)and disease-free survival(DFS),respectively.The hazard ratios(HRs)with 95%confidence intervals(CIs)were combined to assess the association between these indicators and prognosis of osteosarcoma patients.RESULTS A total of 13 studies involving 2087 patients were eventually included.The pooled results demonstrated that higher NLR and GPS were significantly associated with poorer OS(HR=1.88,95%CI:1.38-2.55,P<0.001;HR=2.19,95%CI:1.64-2.94,P<0.001)and DFS(HR=1.67,95%CI:1.37-2.04,P<0.001;HR=2.50,95%CI:1.39-4.48,P<0.001).However,no significant relationship of PLR and LMR and OS(P=0.085;P=0.338)and DFS(P=0.396;P=0.124)was observed.CONCLUSION Higher NLR and GPS were related with worse prognosis and might serve as novel prognostic indicators for osteosarcoma patients.展开更多
目的探讨脑氧摄取率(CERO_(2))、脑氧饱和度(rSO_(2))与重症颅脑损伤神经功能预后不良的关系及其预测神经功能预后的价值。方法回顾性分析2018年1月—2019年6月医院收治的106例重症颅脑损伤术后患者和同时期本院收治的可疑脑损伤但是经...目的探讨脑氧摄取率(CERO_(2))、脑氧饱和度(rSO_(2))与重症颅脑损伤神经功能预后不良的关系及其预测神经功能预后的价值。方法回顾性分析2018年1月—2019年6月医院收治的106例重症颅脑损伤术后患者和同时期本院收治的可疑脑损伤但是经检查健康的96例的资料,分别记为观察组和对照组。对观察组患者随访6个月依据格拉斯哥预后(GOS)评分进行重症颅脑损伤术后神经功能预后评价。对比观察组与对照组脑代谢指标(CERO_(2)、rSO_(2))、观察组中预后良好者与预后不良者术后24 h CERO_(2)、rSO_(2),分析术后24 h CERO_(2)、rSO_(2)与重症颅脑损伤术后神经功能预后不良的关系,分析术后24 h CERO_(2)、rSO_(2)与重症颅脑损伤术后神经功能预后不良的关系及预测价值。结果观察组CERO_(2)、rSO_(2)均低于对照组(P<0.05);重症颅脑损伤术后神经功能预后不良发生率为23.58%;观察组术后神经功能预后不良者术后24 h CERO_(2)、rSO_(2)均低于神经功能预后良好者(P<0.05)。多因素分析显示,年龄、合并基础疾病、开放性颅脑损伤、受伤至手术开始时间、术前格拉斯哥昏迷量表(GCS)评分中特重型、首次开颅手术时间、首次开颅手术中出血量、脑疝形成、颅内感染、康复治疗不依从、术后24 h CERO_(2)和术后24 h rSO_(2)均是重症颅脑损伤术后神经功能预后不良的影响因素(P<0.05);术后24 h CERO_(2)、rSO_(2)联合预测重症颅脑损伤术后神经功能预后不良的灵敏度、曲线下面积(AUC)显著高于单独指标预测(P<0.05)。结论重症颅脑损伤患者术后24 h CERO_(2)、rSO_(2)均偏低,且二者均是重症颅脑损伤术后神经功能预后不良的影响因素,联合预测神经功能预后不良的价值高。展开更多
文摘Objective: This study aims to evaluate the impact and potential prognostic roles of the pre- and post-treatment Glasgow prognostic score (GPS) and the change thereof in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy (CCRT). Methods: We collected GPS and clinicopathological data of 139 stage III, IVA, and IVB head and neck cancer patients who underwent CCRT between 2008 and 2011. Their GPSs pre- and post-CCRT and the change thereof were analyzed for correlations with recurrence and survival. Results: The GPS changed in 72 (51.8%) patients, with worse scores observed post-CCRT in 65 (90.3%) of the GPS changed patients. Patients in the improved GPS group showed a tendency toward better survival. From the multivariate analysis, the post-CCRT GPS level was an independent prognostic factor in addition to tumor stage. Conclusions: After CCRT, a high GPS was revealed to be an important predictor of survival for advanced head and neck cancer.
文摘BACKGROUND Some studies investigated the prognostic role of several blood biomarkers,including the neutrophil/lymphocyte ratio(NLR),platelet/lymphocyte ratio(PLR),lymphocyte/monocyte ratio(LMR)and Glasgow prognostic score(GPS),in osteosarcoma,but their results were inconsistent with each other.AIM To identify the prognostic value of NLR,PLR,LMR and GPS in osteosarcoma patients through reviewing relevant studies.METHODS The PubMed,EMBASE,Web of Science and CNKI databases were searched up to October 2,2021.The primary and second outcomes were overall survival(OS)and disease-free survival(DFS),respectively.The hazard ratios(HRs)with 95%confidence intervals(CIs)were combined to assess the association between these indicators and prognosis of osteosarcoma patients.RESULTS A total of 13 studies involving 2087 patients were eventually included.The pooled results demonstrated that higher NLR and GPS were significantly associated with poorer OS(HR=1.88,95%CI:1.38-2.55,P<0.001;HR=2.19,95%CI:1.64-2.94,P<0.001)and DFS(HR=1.67,95%CI:1.37-2.04,P<0.001;HR=2.50,95%CI:1.39-4.48,P<0.001).However,no significant relationship of PLR and LMR and OS(P=0.085;P=0.338)and DFS(P=0.396;P=0.124)was observed.CONCLUSION Higher NLR and GPS were related with worse prognosis and might serve as novel prognostic indicators for osteosarcoma patients.
文摘目的探讨脑氧摄取率(CERO_(2))、脑氧饱和度(rSO_(2))与重症颅脑损伤神经功能预后不良的关系及其预测神经功能预后的价值。方法回顾性分析2018年1月—2019年6月医院收治的106例重症颅脑损伤术后患者和同时期本院收治的可疑脑损伤但是经检查健康的96例的资料,分别记为观察组和对照组。对观察组患者随访6个月依据格拉斯哥预后(GOS)评分进行重症颅脑损伤术后神经功能预后评价。对比观察组与对照组脑代谢指标(CERO_(2)、rSO_(2))、观察组中预后良好者与预后不良者术后24 h CERO_(2)、rSO_(2),分析术后24 h CERO_(2)、rSO_(2)与重症颅脑损伤术后神经功能预后不良的关系,分析术后24 h CERO_(2)、rSO_(2)与重症颅脑损伤术后神经功能预后不良的关系及预测价值。结果观察组CERO_(2)、rSO_(2)均低于对照组(P<0.05);重症颅脑损伤术后神经功能预后不良发生率为23.58%;观察组术后神经功能预后不良者术后24 h CERO_(2)、rSO_(2)均低于神经功能预后良好者(P<0.05)。多因素分析显示,年龄、合并基础疾病、开放性颅脑损伤、受伤至手术开始时间、术前格拉斯哥昏迷量表(GCS)评分中特重型、首次开颅手术时间、首次开颅手术中出血量、脑疝形成、颅内感染、康复治疗不依从、术后24 h CERO_(2)和术后24 h rSO_(2)均是重症颅脑损伤术后神经功能预后不良的影响因素(P<0.05);术后24 h CERO_(2)、rSO_(2)联合预测重症颅脑损伤术后神经功能预后不良的灵敏度、曲线下面积(AUC)显著高于单独指标预测(P<0.05)。结论重症颅脑损伤患者术后24 h CERO_(2)、rSO_(2)均偏低,且二者均是重症颅脑损伤术后神经功能预后不良的影响因素,联合预测神经功能预后不良的价值高。